Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. / Albert, Nathalie L.; Weller, Michael; Suchorska, Bogdana; Galldiks, Norbert; Soffietti, Riccardo; Kim, Michelle M.; La Fougère, Christian; Pope, Whitney; Law, Ian; Arbizu, Javier; Chamberlain, Marc C.; Vogelbaum, Michael; Ellingson, Ben M.; Tonn, Joerg C.

In: Neuro-Oncology, Vol. 18, No. 9, 09.2016, p. 1199-1208.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Albert, NL, Weller, M, Suchorska, B, Galldiks, N, Soffietti, R, Kim, MM, La Fougère, C, Pope, W, Law, I, Arbizu, J, Chamberlain, MC, Vogelbaum, M, Ellingson, BM & Tonn, JC 2016, 'Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas', Neuro-Oncology, vol. 18, no. 9, pp. 1199-1208. https://doi.org/10.1093/neuonc/now058

APA

Albert, N. L., Weller, M., Suchorska, B., Galldiks, N., Soffietti, R., Kim, M. M., La Fougère, C., Pope, W., Law, I., Arbizu, J., Chamberlain, M. C., Vogelbaum, M., Ellingson, B. M., & Tonn, J. C. (2016). Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology, 18(9), 1199-1208. https://doi.org/10.1093/neuonc/now058

Vancouver

Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro-Oncology. 2016 Sep;18(9):1199-1208. https://doi.org/10.1093/neuonc/now058

Author

Albert, Nathalie L. ; Weller, Michael ; Suchorska, Bogdana ; Galldiks, Norbert ; Soffietti, Riccardo ; Kim, Michelle M. ; La Fougère, Christian ; Pope, Whitney ; Law, Ian ; Arbizu, Javier ; Chamberlain, Marc C. ; Vogelbaum, Michael ; Ellingson, Ben M. ; Tonn, Joerg C. / Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. In: Neuro-Oncology. 2016 ; Vol. 18, No. 9. pp. 1199-1208.

Bibtex

@article{cdcbb056e18c4d7cb63db2ed86074365,
title = "Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas",
abstract = "This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) and amino acid tracers (11C-MET, 18F-FET, and 18F-FDOPA). An increasing number of studies have been published on PET imaging in the setting of diagnosis, biopsy, and resection as well radiotherapy planning, treatment monitoring, and response assessment. Recommendations are based on evidence generated from studies which validated PET findings by histology or clinical course. This guideline emphasizes the clinical value of PET imaging with superiority of amino acid PET over glucose PET and provides a framework for the use of PET to assist in the management of patients with gliomas.",
keywords = "amino acid PET, glioma, guideline, PET imaging, recommendations",
author = "Albert, {Nathalie L.} and Michael Weller and Bogdana Suchorska and Norbert Galldiks and Riccardo Soffietti and Kim, {Michelle M.} and {La Foug{\`e}re}, Christian and Whitney Pope and Ian Law and Javier Arbizu and Chamberlain, {Marc C.} and Michael Vogelbaum and Ellingson, {Ben M.} and Tonn, {Joerg C.}",
year = "2016",
month = sep,
doi = "10.1093/neuonc/now058",
language = "English",
volume = "18",
pages = "1199--1208",
journal = "Neuro-Oncology",
issn = "1522-8517",
publisher = "Oxford University Press",
number = "9",

}

RIS

TY - JOUR

T1 - Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

AU - Albert, Nathalie L.

AU - Weller, Michael

AU - Suchorska, Bogdana

AU - Galldiks, Norbert

AU - Soffietti, Riccardo

AU - Kim, Michelle M.

AU - La Fougère, Christian

AU - Pope, Whitney

AU - Law, Ian

AU - Arbizu, Javier

AU - Chamberlain, Marc C.

AU - Vogelbaum, Michael

AU - Ellingson, Ben M.

AU - Tonn, Joerg C.

PY - 2016/9

Y1 - 2016/9

N2 - This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) and amino acid tracers (11C-MET, 18F-FET, and 18F-FDOPA). An increasing number of studies have been published on PET imaging in the setting of diagnosis, biopsy, and resection as well radiotherapy planning, treatment monitoring, and response assessment. Recommendations are based on evidence generated from studies which validated PET findings by histology or clinical course. This guideline emphasizes the clinical value of PET imaging with superiority of amino acid PET over glucose PET and provides a framework for the use of PET to assist in the management of patients with gliomas.

AB - This guideline provides recommendations for the use of PET imaging in gliomas. The review examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) and amino acid tracers (11C-MET, 18F-FET, and 18F-FDOPA). An increasing number of studies have been published on PET imaging in the setting of diagnosis, biopsy, and resection as well radiotherapy planning, treatment monitoring, and response assessment. Recommendations are based on evidence generated from studies which validated PET findings by histology or clinical course. This guideline emphasizes the clinical value of PET imaging with superiority of amino acid PET over glucose PET and provides a framework for the use of PET to assist in the management of patients with gliomas.

KW - amino acid PET

KW - glioma

KW - guideline

KW - PET imaging

KW - recommendations

U2 - 10.1093/neuonc/now058

DO - 10.1093/neuonc/now058

M3 - Journal article

C2 - 27106405

AN - SCOPUS:84985991671

VL - 18

SP - 1199

EP - 1208

JO - Neuro-Oncology

JF - Neuro-Oncology

SN - 1522-8517

IS - 9

ER -

ID: 179222552